These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 14562286)

  • 1. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.
    Abraham SC; Lee JH; Hruban RH; Argani P; Furth EE; Wu TT
    Hum Pathol; 2003 Sep; 34(9):902-10. PubMed ID: 14562286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability in intraductal papillary neoplasms of the biliary tract.
    Abraham SC; Lee JH; Boitnott JK; Argani P; Furth EE; Wu TT
    Mod Pathol; 2002 Dec; 15(12):1309-17. PubMed ID: 12481012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
    Schlitter AM; Born D; Bettstetter M; Specht K; Kim-Fuchs C; Riener MO; Jeliazkova P; Sipos B; Siveke JT; Terris B; Zen Y; Schuster T; Höfler H; Perren A; Klöppel G; Esposito I
    Mod Pathol; 2014 Jan; 27(1):73-86. PubMed ID: 23828315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.
    Abraham SC; Wu TT; Klimstra DS; Finn LS; Lee JH; Yeo CJ; Cameron JL; Hruban RH
    Am J Pathol; 2001 Nov; 159(5):1619-27. PubMed ID: 11696422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
    Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
    Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.
    Abraham SC; Wu TT; Hruban RH; Lee JH; Yeo CJ; Conlon K; Brennan M; Cameron JL; Klimstra DS
    Am J Pathol; 2002 Mar; 160(3):953-62. PubMed ID: 11891193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
    Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
    Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
    Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
    Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterisation of six human biliary tract cancer cell lines.
    Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
    Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.
    Abraham SC; Klimstra DS; Wilentz RE; Yeo CJ; Conlon K; Brennan M; Cameron JL; Wu TT; Hruban RH
    Am J Pathol; 2002 Apr; 160(4):1361-9. PubMed ID: 11943721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GNAS Is frequently mutated in a specific subgroup of intraductal papillary neoplasms of the bile duct.
    Tsai JH; Yuan RH; Chen YL; Liau JY; Jeng YM
    Am J Surg Pathol; 2013 Dec; 37(12):1862-70. PubMed ID: 24061513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: a prospective study in more than 100 patients.
    Müller P; Ostwald C; Püschel K; Brinkmann B; Plath F; Kröger J; Barten M; Nizze H; Schareck WD; Hauenstein K; Liebe S; Löhr JM
    Eur J Clin Invest; 2001 Mar; 31(3):240-7. PubMed ID: 11264652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
    Sasaki M; Sato Y
    Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct.
    Matthaei H; Wu J; Dal Molin M; Debeljak M; Lingohr P; Katabi N; Klimstra DS; Adsay NV; Eshleman JR; Schulick RD; Kinzler KW; Vogelstein B; Hruban RH; Maitra A
    HPB (Oxford); 2012 Oct; 14(10):677-83. PubMed ID: 22954004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.
    Schlitter AM; Jang KT; Klöppel G; Saka B; Hong SM; Choi H; Offerhaus GJ; Hruban RH; Zen Y; Konukiewitz B; Regel I; Allgäuer M; Balci S; Basturk O; Reid MD; Esposito I; Adsay V
    Mod Pathol; 2015 Sep; 28(9):1249-64. PubMed ID: 26111977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct.
    Tsai JH; Liau JY; Yuan CT; Cheng ML; Yuan RH; Jeng YM
    Histopathology; 2017 Apr; 70(5):756-765. PubMed ID: 27864998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different carcinogenic process in cholangiocarcinoma cases epidemically developing among workers of a printing company in Japan.
    Sato Y; Kubo S; Takemura S; Sugawara Y; Tanaka S; Fujikawa M; Arimoto A; Harada K; Sasaki M; Nakanuma Y
    Int J Clin Exp Pathol; 2014; 7(8):4745-54. PubMed ID: 25197345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the fragile histidine triad gene in intrahepatic cholangiocarcinoma.
    Koch E; Fiedler W; Tannapfel A; Ballhausen WG
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):907-13. PubMed ID: 12867802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.